NDC 24208-002

VITRASE

Hyaluronidase, Ovine

VITRASE is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Bausch & Lomb Incorporated. The primary component is Hyaluronidase, Ovine.

• Product ID: 24208-002_22bb835d-0433-4e75-bada-5cb60113d298
• NDC: 24208-002
• Product Type: Human Prescription Drug
• Proprietary Name: VITRASE
• Generic Name: Hyaluronidase, Ovine
• Dosage Form: Injection, Solution
• Route of Administration: SUBCUTANEOUS
• Marketing Start Date: 2005-02-01
• Marketing Category: BLA / NDA
• Application Number: BLA021640
• Labeler Name: Bausch & Lomb Incorporated
• Substance Name: HYALURONIDASE, OVINE
• Active Ingredient Strength: 200 [USP'U]/mL
• Pharm Classes: Endoglycosidase [EPC],Glycoside Hydrolases [CS]
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 24208-002-02

2 VIAL, SINGLE-USE in 1 CARTON (24208-002-02) > 1.2 mL in 1 VIAL, SINGLE-USE

• Marketing Start Date: 2005-02-01
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 24208-002-01 [24208000201]

VITRASE INJECTION, SOLUTION

• Marketing Category: NDA
• Application Number: NDA021640
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2005-02-01
• Marketing End Date: 2017-12-29

NDC 24208-002-02 [24208000202]

VITRASE INJECTION, SOLUTION

• Marketing Category: NDA
• Application Number: NDA021640
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: ML
• Marketing Start Date: 2005-02-01

Drug Details

Active Ingredients

Ingredient	Strength
HYALURONIDASE, OVINE	200 [USP'U]/mL

OpenFDA Data

• SPL SET ID: 21fbd12e-4a12-4ad1-ad01-964cd5ec9996
• Manufacturer:
  • Bausch & Lomb Incorporated
• UNII:
  • 64R4OHP8T0
• RxNorm Concept Unique ID - RxCUI:
  • 486166
  • 582692

Pharmacological Class

• Endoglycosidase [EPC]
• Glycoside Hydrolases [CS]